Back

Preliminary results of a feasibility study to evaluate the effect of concomitant renal denervation and cardiac ablation on atrial fibrillation recurrence

18 June 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Atrial Fibrillation - Catheter ablation Catheter ablation (Atrial Fibrillation) EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Doctor Bettina Kirstein

Schleswig-Holstein University Clinic, Lubeck Campus, Luebeck (Germany)

65 More presentations in this session

Presentation thumbnail
Doctor C. Lin (Copenhagen, DK)
Presentation thumbnail
Doctor C. Lin (Copenhagen, DK)
Presentation thumbnail
Professor C. Sohns (Bad Oeynhausen, DE)
Abstract
Presentation thumbnail
Doctor F. Kece (Leuven, BE)
Abstract
Presentation thumbnail
Doctor T. Schreiber (Berlin, DE)
Abstract

Access the full session

Session thumbnail
Poster session 1 - Atrial Fibrillation - Catheter ablation

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

18 June 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Pulmonary vein isolation versus PVI + adjunctive strategy (substrate modification and renal denervation therapy) for the reduction of 12-month AF recurrence
27 August 2023
thumbnail
Congress Session
Atrial fibrillation (1)
31 March 2025
thumbnail
Congress Presentation
Use of renal denervation in the electrical storm management
3 September 2019
thumbnail
Congress Presentation
Cutting down time and radiation in atrial fibrillation ablation: lessons from four workflow setups
30 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources